Science 37 Holdings Stock Current Liabilities
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
Science 37 Holdings fundamentals help investors to digest information that contributes to Science 37's financial success or failures. It also enables traders to predict the movement of Science Stock. The fundamental analysis module provides a way to measure Science 37's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Science 37 stock.
Science |
Science 37 Holdings Company Current Liabilities Analysis
Science 37's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Science 37 Holdings has a Current Liabilities of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Science Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Science 37's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Science 37 could also be used in its relative valuation, which is a method of valuing Science 37 by comparing valuation metrics of similar companies.Science 37 is currently under evaluation in current liabilities category among its peers.
Science Fundamentals
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | (21.22 M) | |||
| Shares Outstanding | 6.03 M | |||
| Shares Owned By Insiders | 16.89 % | |||
| Shares Owned By Institutions | 52.18 % | |||
| Number Of Shares Shorted | 13.83 K | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 60.26 M | |||
| Gross Profit | 20.07 M | |||
| EBITDA | (59.86 M) | |||
| Net Income | (124.65 M) | |||
| Cash And Equivalents | 130.24 M | |||
| Cash Per Share | 1.12 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 6.32 X | |||
| Book Value Per Share | 8.69 X | |||
| Cash Flow From Operations | (48.19 M) | |||
| Short Ratio | 0.22 X | |||
| Earnings Per Share | (21.40) X | |||
| Target Price | 13.83 | |||
| Number Of Employees | 460 | |||
| Beta | 0.56 | |||
| Market Capitalization | 34.66 M | |||
| Total Asset | 126.45 M | |||
| Retained Earnings | (253.07 M) | |||
| Working Capital | 103.03 M | |||
| Z Score | 12.82 | |||
| Net Asset | 126.45 M |
About Science 37 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Science 37 Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Science 37 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Science 37 Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |